Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization
- PMID: 24484217
- PMCID: PMC4317797
- DOI: 10.1111/cas.12365
Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization
Abstract
A mimotope is an antibody-epitope-mimicking peptide retrieved from a phage display random peptide library. Immunization with antitumor antibody-derived mimotopes is promising for inducing antitumor immunity in hosts. In this study, we isolated linear and constrained mimotopes from HBJ127, a tumor-suppressing anti-CD98 heavy chain mAb, and determined their abilities for induction of antitumor activity equal to that of the parent antibody. We detected elevated levels of antipeptide responses, but failed to detect reactivity against native CD98-expressing HeLa cells in sera of immunized mice. Phage display panning and selection of mimotope-immunized mouse spleen-derived antibody Fab library showed that HeLa cell-reactive Fabs were successfully retrieved from the library. This finding indicates that native antigen-reactive Fab clones represented an undetectable minor population in mimotope-induced antibody repertoire. Functional and structural analysis of retrieved Fab clones revealed that they were almost identical to the parent antibody. From these results, we confirmed that mimotope immunization was promising for retrieving antitumor antibodies equivalent to the parent antibody, although the co-administration of adjuvant compounds such as T-cell epitope peptides and Toll-like receptor 4 agonist peptides is likely to be necessary for inducing stronger antitumor immunity than mimotope injection alone.
Keywords: CD98; mimotope; monoclonal antibody; phage display; recombinant Fab.
© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
Figures




Similar articles
-
Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein.Cancer Sci. 2009 Jan;100(1):126-31. doi: 10.1111/j.1349-7006.2008.00998.x. Epub 2008 Oct 29. Cancer Sci. 2009. PMID: 19018757 Free PMC article.
-
Identification of cell proliferation-associated epitope on CD98 oncoprotein using phage display random peptide library.Cancer Sci. 2007 Nov;98(11):1696-700. doi: 10.1111/j.1349-7006.2007.00587.x. Epub 2007 Aug 16. Cancer Sci. 2007. PMID: 17711505 Free PMC article.
-
High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.Cancer Immunol Immunother. 2005 Jul;54(7):677-84. doi: 10.1007/s00262-004-0632-7. Epub 2004 Nov 24. Cancer Immunol Immunother. 2005. PMID: 15565329 Free PMC article.
-
Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella.Int Rev Immunol. 2001;20(2):181-99. doi: 10.3109/08830180109043033. Int Rev Immunol. 2001. PMID: 11878764 Review.
-
Mimotope vaccination--from allergy to cancer.Expert Opin Biol Ther. 2009 Apr;9(4):493-506. doi: 10.1517/14712590902870386. Expert Opin Biol Ther. 2009. PMID: 19344285 Free PMC article. Review.
Cited by
-
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.Adv Exp Med Biol. 2021;21:13-127. doi: 10.1007/5584_2020_584. Adv Exp Med Biol. 2021. PMID: 33052588 Review.
-
CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb.FEBS Open Bio. 2025 May;15(5):867-884. doi: 10.1002/2211-5463.13963. Epub 2025 Jan 5. FEBS Open Bio. 2025. PMID: 39757718 Free PMC article.
-
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.Cancer Sci. 2019 Feb;110(2):674-685. doi: 10.1111/cas.13908. Epub 2019 Jan 4. Cancer Sci. 2019. PMID: 30548114 Free PMC article.
-
Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer.Infect Agent Cancer. 2018 Apr 2;13:11. doi: 10.1186/s13027-018-0184-7. eCollection 2018. Infect Agent Cancer. 2018. PMID: 29619076 Free PMC article.
References
-
- Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther. 1999;21:309–18. - PubMed
-
- Anderson DR, Grillo-López A, Varns C, Chambers KS, Hanna N. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans. 1997;25:705–8. - PubMed
-
- Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552–63. - PubMed
-
- Riemer AB, Kurz H, Klinger M, Scheiner O, Zielinski CC, Jensen-Jarolim E. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J Natl Cancer Inst. 2005;97:1663–70. - PubMed
-
- Li M, Yan Z, Han W, Zhang Y. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies. Cell Immunol. 2006;239:136–43. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources